Smith Group Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Smith Group Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$218K	Sell	3,490 -110	-3%	-$6.95K	0.01%	142
2026 Q2	$207K	Sell	3,600 -10,250	-74%	-$589K	0.01%	165
2026 Q1	$840K	Buy	+13,850	New	+$807K	0.04%	99
2020 Q4	–	Sell	-323,739	Closed	-$19.5M	–	313
2020 Q3	$19.5M	Sell	323,739 -240,591	-43%	-$14.5M	1.02%	33
2020 Q2	$33.2M	Sell	564,330 -236,650	-30%	-$14.2M	1.83%	14
2020 Q1	$44.7M	Sell	800,980 -79,162	-9%	-$4.84M	2.44%	8
2019 Q4	$56.5M	Sell	880,142 -298,401	-25%	-$17.1M	2.37%	8
2019 Q3	$59.8M	Sell	1,178,543 -18,601	-2%	-$874K	2.1%	9
2019 Q2	$54.3M	Sell	1,197,144 -48,542	-4%	-$2.26M	1.82%	13
2019 Q1	$59.4M	Sell	1,245,686 -5,251	-0.4%	-$262K	1.93%	14
2018 Q4	$65M	Buy	1,250,937 +572,380	+84%	+$30.8M	2.29%	9
2018 Q3	$42.1M	Buy	+678,557	New	+$40.3M	1.2%	28
2016 Q3	–	Sell	-990,710	Closed	-$72.9M	–	455
2016 Q2	$72.9M	Buy	990,710 +807,050	+439%	+$57M	2.18%	9
2016 Q1	$11.7M	Buy	183,660 +18,080	+11%	+$1.14M	0.35%	82
2015 Q4	$11.4M	Buy	+165,580	New	+$10.9M	0.34%	81

Other funds holding BMY

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Primecap Management Pasadena, California $161B AUM 86.05% 1-Year Est. Return

Independent Franchise Partners London, United Kingdom $16.1B AUM 4.39% 1-Year Est. Return

Smith Group Asset Management's BMY Position: Q3 2026 in Review

Smith Group Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 3.1% in Q3 2026, selling an estimated $6.95K and leaving 3,490 shares worth $218K. The position accounts for 0.01% of the portfolio, ranked #142.

Smith Group Asset Management first reported a position in BMY in Q4 2015 and has held it in 15 quarters since. The position peaked at $72.9M in Q2 2016. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Smith Group Asset Management held 3,490 shares of Bristol-Myers Squibb worth $218K as of Q3 2026.
Smith Group Asset Management sold 110 Bristol-Myers Squibb shares in Q3 2026, an estimated $6.95K.
Bristol-Myers Squibb made up 0.01% of Smith Group Asset Management's portfolio in Q3 2026, its #142 holding.
Smith Group Asset Management first reported a position in Bristol-Myers Squibb in Q4 2015 and has held it in 15 quarters since.
Smith Group Asset Management's Bristol-Myers Squibb position peaked at $72.9M in Q2 2016.
2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Smith Group Asset Management's 13F filing for Q3 2026, filed 27 Oct 2026.